Oscotec Inc.

Translating science into medicine
Sign Up

Sign Up

Sign In
PRESS

NEWSROOM

Notice Press Releases Publications IR Materials
Home NEWSROOM Press Releases
TDefault
✔ Go Website with Viewer Search Write
List of Articles
Date Website Media Pipeline
2018-06-03 "ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC" Businesswire Lazertinib
Board Pagination Prev 1 2 3 Next
/ 3
© k2s0o1d6e0s8i2g7n. ALL RIGHTS RESERVED.
Requesting to the server, please wait.